Synonyms: ARQ-751 | GLXC-26917
Compound class:
Synthetic organic
Comment: Vevorisertib (GLXC-26917, and formerly ARQ-751) is an allosteric, pan-AKT inhibitor that was designed for anti-tumour potential. The vevorisertib programme was terminated (for business reasons).
|
|